DigitalCommons@SHU

Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections, I.P. Lodding, H. Sengeløv, C. da Cunha-Bang, M. Iversen, A. Rasmussen, F. Gustafsson, J.G. Downing, J. Grarup, N. Kirkby, C.M. Frederiksen, A. Mocroft, S.S. Sørensen, J.D. Lundgren
Maura Iversen

WS1.5 First evidence of Mycobacterium abscessus biofilm in the lungs of chronically infected CF patients, T. Qvist, S.R. Eickhardt-Sørensen, T.L. Katzenstein, T. Pressler, M. Iversen, C.B. Andersen, T. Bjarnsholt, N. Høiby
Maura Iversen

Time after Lung Transplantation Influence the Correlation between Acute Rejection and Frequency of Regulatory T Cells in Transbronchial Lung Biopsies, D. Krustrup, M. Iversen, C.B. Andersen
Maura Iversen

The Time Course of Development and Impact From Viral Resistance Against Ganciclovir in Cytomegalovirus Infection, C. da Cunha‐Bang, C. da Cunha‐Bang, N. Kirkby, M. Sønderholm, S. S. Sørensen, H. Sengeløv, M. Iversen, A. Rasmussen, F. Gustafsson, C. M. Frederiksen, J. Kjær, A. Cozzi Lepri, J. D. Lundgren, J. D. Lundgren
Maura Iversen

Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. Am J Transplant 2010;10:1228–1237, C. da Cunha-Bang, M. Iversen, S. A. Mortensen, A. Rasmussen, H. Sengeløv, S. S. Sørensen, J. Lundgren
Maura Iversen

Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients, C. Da Cunha-Bang, M. Iversen, S. A. Mortensen, A. Rasmussen, H. Sengeløv, S. S. Sørensen, J. Lundgren
Maura Iversen

Response to O’Connell and Colleagues, M. Hornum, M. Iversen, B. Feldt‐Rasmussen
Maura Iversen

Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantation., M. Hornum, M. Iversen, I. Steffensen, P. Hovind, J. Carlsen, L. W. Andersen, D. A. Steinbrüchel, B. Feldt-Rasmussen
Maura Iversen

530: Microarray Based Measurement of Autoantibodies Identifies Early Development of BOS in Lung Transplant Patients, Peter Hagedorn, C.M. Burton, D. Steinbruchel, E. Sahar, Henrik K. Flyvbjerg, M. Iversen
Maura Iversen

A comparison between antithymocyte globulin and dacluzimab induction therapy for lung transplantation. A retrospective analysis of the frequency of acute cellular rejection in 270 patients, C.M. Burton, A.S. Jensen, S. Boesgaard, N. Milman, H. Arendrup, K. Eliasen, C.B. Andersen, M. Iversen, J. Carlsen
Maura Iversen